Substance-related poisonings and injuries in Canada have received increasing attention in recent years due to emerging public health concerns, such as the opioid overdose crisis, the introduction of synthetic cannabinoids to the illicit market and the emergence of electronic cigarettes/vaping products on the Canadian market. Furthermore, there has been a general increase in substance-related hospitalizations
Youth age 12 – 18 who use marijuana are 4 – 7 times more likely than adults to develop a cannabis use disorder.
Like this article?
Leave a comment
Changes in Rates of Hospitalizations due to Cannabis Harms in Ontario, Canada Before the Legalization of Nonmedical Cannabis: Retrospective Population-level Study Between 2003 and 2017
There are distinct patterns of hospitalizations due to cannabis harms in different priority populations. Young women aged 15 to 24 are a key demographic that is disproportionately burdened with a rapid increase in hospitalizations due to cannabis harms. Jurisdictions considering new approaches to cannabis control policy and addiction services should consider the rising burden of
Nonmedical (“recreational”) cannabis use and cannabis laws have changed over the past two decades in the United States (1) and the rest of the world (2). Increasing use, especially among the young, coupled with the increasing potency of cannabis (higher delta-9-tetrahydrocannabinol [THC] content) during this period (3), has raised concerns about the long-term health impact
IASIC Speaker Series Presents Where Does Cannabis Go in the Body and How It May Affect Teenagers’ Brain?
The International Academy on the Science and Impact of Cannabis (IASIC) is excited to present the IASIC Speaker Series. Presented free of charge, this ongoing educational seminar series will focus on the science, data and peer-reviewed research surrounding marijuana and will be led by international medical experts. This non-partisan and non-political series is continually developed,
Three Years After Legalization, Canada Has Little Information About How It Changed Cannabis Use and Health Harms
In an editorial piece penned by Public Health Physician and Canadian Institutes of Health Research Fellow Daniel Myran for The Conversation, Dr. Myran explains the lack of timely and current data on recreational cannabis legalization before a mandated review of the health impacts. He cites three main areas that limit the understanding of legalization’s health
Sir Robin Murray, a professor at King’s College London, issued stern words of warning in a new interview: has caused psychosis in around 30 percent of the patients he sees at his practice in south London. “I think we’re now 100 percent sure that cannabis is one of the causes of a schizophrenia-like psychosis,” he